Analyze Diet
Journal of medical microbiology2023; 72(7); doi: 10.1099/jmm.0.001730

JMM Profile: West Nile virus.

Abstract: West Nile virus (WNV) is a positive-sense single-stranded RNA virus belonging to the Flaviviridae family and is maintained in an enzootic cycle between avian hosts and mosquito vectors. Humans, horses and other mammals are susceptible to infection but are dead-end hosts due to a low viraemia. The disease can manifest itself in a variety of clinical signs and symptoms in people and horses from mild fever to severe encephalitis and morbidity. There are no vaccines licensed for human protection, but parts of Europe, North America, Africa and Australia have vaccines commercially available for horses.
Publication Date: 2023-07-17 PubMed ID: 37459154DOI: 10.1099/jmm.0.001730Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article is about the West Nile virus (WNV), an RNA virus that typically spreads between mosquito vectors and bird hosts, but can also infect mammals including humans and horses. The article describes the disease symptoms which can range from mild fever to severe encephalitis, and mentions that there are currently no licensed vaccines for human protection.

West Nile Virus and Its Cycle

  • West Nile Virus (WNV) is a type of RNA virus that falls under the Flaviviridae family.
  • The virus is maintained primarily in a cycle between avian hosts and mosquito vectors. This cycle involves the virus being transmitted from infected birds to mosquitos who then go on to infect other birds, continuing the cycle.
  • Mammals including humans and horses can also be infected by the virus, however they are referred to as “dead-end hosts”.
  • This is because these mammals, after getting infected, do not produce enough of the virus in their blood to contribute to the transmission cycle, making them a kind of biological “dead end” for the virus.

Clinical Signs and Symptoms

  • The symptoms of West Nile Virus in humans and horses can vary greatly in severity.
  • It can cause mild fever in some cases, but in severe cases it could lead to encephalitis, a type of brain inflammation that can increase morbidity rates.
  • Morbidity refers to the number of people who have a disease compared to the total number of people in a population. In this context, it means that encephalitis can increase the number of people who are ill in a population.

Availability of Vaccines

  • Currently, there are no vaccines available that are licensed for protection against the West Nile Virus in humans.
  • However, in certain regions such as parts of Europe, North America, Africa, and Australia, vaccines are commercially available for horses.

Cite This Article

APA
Sewgobind S, McCracken F, Schilling M. (2023). JMM Profile: West Nile virus. J Med Microbiol, 72(7). https://doi.org/10.1099/jmm.0.001730

Publication

ISSN: 1473-5644
NlmUniqueID: 0224131
Country: England
Language: English
Volume: 72
Issue: 7

Researcher Affiliations

Sewgobind, Sanam
  • Virology Department, Animal and Plant Health Agency, Woodham Lane, Addlestone, Surrey, KT15 3NB, UK.
McCracken, Fiona
  • Virology Department, Animal and Plant Health Agency, Woodham Lane, Addlestone, Surrey, KT15 3NB, UK.
Schilling, Mirjam
  • Virology Department, Animal and Plant Health Agency, Woodham Lane, Addlestone, Surrey, KT15 3NB, UK.

MeSH Terms

  • Humans
  • Animals
  • Horses
  • West Nile virus / genetics
  • West Nile Fever / veterinary
  • West Nile Fever / diagnosis
  • Mammals
  • Europe
  • Africa

Citations

This article has been cited 3 times.
  1. Padalino P, Secco L, Grosso E, Franchetti G, Palumbi S, Giordano R, Viel G. Fatal West Nile Encephalomyelitis in a Young Woman with Hypoparathyroidism and Sjögren's Syndrome. Molecular Insights into Viral Neuro-Invasivity. Int J Mol Sci 2025 Dec 22;27(1).
    doi: 10.3390/ijms27010104pubmed: 41515984google scholar: lookup
  2. Bruno L, Nappo MA, Frontoso R, Perrotta MG, Di Lecce R, Guarnieri C, Ferrari L, Corradi A. West Nile Virus (WNV): One-Health and Eco-Health Global Risks. Vet Sci 2025 Mar 19;12(3).
    doi: 10.3390/vetsci12030288pubmed: 40266979google scholar: lookup
  3. Weiß R, Issmail L, Rockstroh A, Grunwald T, Fertey J, Ulbert S. Immunization with different recombinant West Nile virus envelope proteins induces varying levels of serological cross-reactivity and protection from infection. Front Cell Infect Microbiol 2023;13:1279147.
    doi: 10.3389/fcimb.2023.1279147pubmed: 38035335google scholar: lookup